HER2 and 3 play also essential roles in the development of brain metastasis which causes death of more than 30% of stage IV HER2+ breast cancer patients (Berghoff et al, 2014; Da Silva et al, 2010; Fecci et al, 2019). Here, ERBB2 is linked to breast cancer.